Publications

  1. Virk A, Pritt B, Patel R, Uhl JR, Bezalel SA, Gibson LE, Stryjewska BM, Peters MS. Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas. Emerg Infect Dis. 2017 Nov; 23 (11):1864-1866
    View PubMed
  2. Tan EM, Nagpal A, DeSimone DC, Anderson B, Linderbaum J, De Ziel T, Li Z, Sohail MR, Cha YM, Loomis E, Espinosa R, Friedman PA, Greason K, Schiller H, Virk A, Wilson WR, Steckelberg JM, Baddour LM. Impacts of a care process model and inpatient electrophysiology service on cardiovascular implantable electronic device infections: a preliminary evaluation. J Interv Card Electrophysiol. 2017 Oct; 50 (1):117-124 Epub 2017 Aug 26
    View PubMed
  3. Tan EM, DeSimone DC, Sohail MR, Baddour LM, Wilson WR, Steckelberg JM, Virk A. Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression. Clin Infect Dis. 2017 Jun 01; 64: (11)1516-1521.
    View PubMed
  4. Frazee E, Rule AD, Lieske JC, Kashani KB, Barreto JN, Virk A, Kuper PJ, Dierkhising RA, Leung N. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project. Am J Kidney Dis. 2017 May; 69: (5)658-666.
    View PubMed
  5. Tyner HL, Virk A, Nassr A, Razonable R. Mycoplasma hominis vertebral spine infection: Case report and a review of infections of bone and joints. J Infect Chemother. 2016 Nov; 22: (11)755-758.
    View PubMed
  6. Mushtaq A, Greenwood-Quaintance KE, Cole NC, Kohner PC, Ihde SM, Strand GJ, Harper LW, Virk A, Patel R. Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva. Antimicrob Agents Chemother. 2016 Aug; 60 (8):5036-9 Epub 2016 July 22
    View PubMed
  7. Tan EM, Marcelin JR, Mason E, Virk A. Mycobacterium avium intracellulare complex causing olecranon bursitis and prosthetic joint infection in an immunocompromised host Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2016; 2:1-4.
  8. Tan EM, Marcelin JR, Virk A. A 24-Year-Old Traveler With an Insect Bite and Rash. Clin Infect Dis. 2015 Oct 15; 61(8):1342-3.
    View PubMed
  9. Tan E, Marcelin JR, Virk A. 44-Year-Old Man With Left-Sided Paresthesias and Homonymous Hemianopsia. Mayo Clin Proc. 2015 Sep; 90: (9)1278-82.
    View PubMed
  10. Greenwood-Quaintance KE, Kohner P, Osmon DR, Virk A, Patel R. Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection. Diagn Microbiol Infect Dis. 2015 Jun; 82: (2)177-8.
    View PubMed
  11. Gupta A, Berbari EF, Osmon DR, Virk A. Prosthetic joint infection due to Salmonella species: a case series. BMC Infect Dis. 2014 Nov 26; 14:633.
    View PubMed
  12. Gomez E, Kennedy CC, Gottschalk M, Cunningham SA, Patel R, Virk A. Streptococcus suis-related prosthetic joint infection and streptococcal toxic shock-like syndrome in a pig farmer in the United States. J Clin Microbiol. 2014 Jun; 52: (6)2254-8.
    View PubMed
  13. Frazee EN, Rule AD, Herrmann SM, Kashani KB, Leung N, Virk A, Voskoboev N, Lieske JC. Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: A cohort study. Crit. Care. 2014; 18(3):R110.
    View PubMed
  14. Virk A, Mandrekar J, Berbari EF, Boyce TG, Fischer PR, Kasten MJ, Orenstein R, Rosenblatt JE, Sampathkumar P, Sia I, Springer D, Witzig TE. A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea. J Travel Med. 2013 Mar-Apr; 20(2):88-94. Epub 2013 Jan 25.
    View PubMed
  15. Alasmari FA, Tleyjeh IM, Riaz M, Greason KL, Berbari EF, Virk A, Baddour LM. Temporal trends in the incidence of surgical site infections in patients undergoing coronary artery bypass graft surgery: a population-based cohort study, 1993 to 2008. Mayo Clin Proc. 2012 Nov; 87: (11)1054-61.
    View PubMed
  16. Agyemang EA, Virk A. 57-Year-old man with fever, rash, chronic watery diarrhea, cough, and sweats. Mayo Clin Proc. 2012 Nov; 87(11):e83-6.
    View PubMed
  17. El Helou OC, Berbari EF, Lahr BD, Eckel-Passow JE, Razonable RR, Sia IG, Virk A, Walker RC, Steckelberg JM, Wilson WR, Hanssen AD, Osmon DR. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010 Aug; 29 (8):961-7 Epub 2010 May 27
    View PubMed
  18. Berbari EF, Osmon DR, Carr A, Hanssen AD, Baddour LM, Greene D, Kupp LI, Baughan LW, Harmsen WS, Mandrekar JN, Therneau TM, Steckelberg JM, Virk A, Wilson WR. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis. 2010 Jan 1; 50(1):8-16.
    View PubMed
  19. Tsigrelis C, Tleyjeh IM, Huskins WC, Lahr BD, Nyre LM, Virk A, Baddour LM. Incidence of invasive pneumococcal disease among children after introduction of a 7-valent pneumococcal conjugate vaccine: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2009 Oct; 84(10):871-5.
    View PubMed
  20. Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM. Trends in invasive pneumococcal disease among older adults in Olmsted County, Minnesota. J Infect. 2009 Sep; 59: (3)188-93.
    View PubMed
  21. Reyburn AM, Virk A. 22-year-old woman with fever and jaundice after travel to Ghana. Mayo Clin Proc. 2009 May; 84(5):461-4.
    View PubMed
  22. Sohail MR, Gray AL, Baddour LM, Tleyjeh IM, Virk A. Infective endocarditis due to Propionibacterium species. Clin Microbiol Infect. 2009 Apr; 15(4):387-94. Epub 2009 Mar 02.
    View PubMed
  23. Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM. Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study. Clin Infect Dis. 2008 Dec 01; 47: (11)1367-71.
    View PubMed
  24. Anastassiades CP, Virk A. From gut to bone. Am J Med. 2008 Sep; 121(9):767-9.
    View PubMed
  25. Uslan DZ, Patel R, Virk A. International travel and exposure risks in solid-organ transplant recipients. Transplantation. 2008 Aug 15; 86(3):407-12.
    View PubMed
  26. Lassmann B, Tsigrelis C, Virk A. 33-year-old woman with marked eosinophilia. Mayo Clin Proc. 2007 Jan; 82(1):103-6.
    View PubMed
  27. Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol. 2006 Oct; 142(10):1287-92.
    View PubMed
  28. Tleyjeh IM, Georgescu G, Virk A, Barajas ED, Mirzoyev Z, Anavekar N, Baddour LM. Cytomegalovirus cholangitis presenting with recurrent hemobilia. Eur J Clin Microbiol Infect Dis. 2005 Sep; 24 (9):634-6
    View PubMed
  29. Uslan DZ, Virk A. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers. J Travel Med. 2005 Jan-Feb; 12(1):14-8.
    View PubMed
  30. Virk A, Fischer PR. Travel medicine: An American view of the Australian perspective. Travel Medicine & Infectious Disease. 2005; 3(2):77-9.
    View PubMed
  31. Meehan AM, Virk A, Swanson K, Poeschla EM. Severe pleuropulmonary paragonimiasis 8 years after emigration from a region of endemicity. Clin Infect Dis. 2002 Jul 01; 35: (1)87-90.
    View PubMed
  32. Virk A. Medical advice for international travelers. Mayo Clin Proc. 2001 Aug; 76(8):831-40.
    View PubMed
  33. Virk A, Osmon DR. Prosthetic joint infection: Current treatment ooptions. Current Treatment Options in Infectious Diseases. 2001; 3(4):287-301.
  34. Virk A, Steckelberg JM. Clinical aspects of antimicrobial resistance. Mayo Clin Proc. 2000 Feb; 75(2):200-14.
    View PubMed
  35. Fischer PR, Virk A. Travel Advisory. In: Primary Care Reports. 1999.